Cisplatin News and Research

RSS
Research shines new light on deadly medulloblastoma metastases

Research shines new light on deadly medulloblastoma metastases

Repressing a protein that facilitates DNA repair to potentiate chemotherapy

Repressing a protein that facilitates DNA repair to potentiate chemotherapy

Superoxide produced in the inner ear cochlea causes major types of acquired hearing loss

Superoxide produced in the inner ear cochlea causes major types of acquired hearing loss

Targeting mTOR pathway can improve the effectiveness of chemotherapies for pediatric brain cancer

Targeting mTOR pathway can improve the effectiveness of chemotherapies for pediatric brain cancer

Scientists identify receptor in cells that could be key to preventing cancer drug-induced hearing loss

Scientists identify receptor in cells that could be key to preventing cancer drug-induced hearing loss

Study paves way for effective monitoring of chemotherapeutic drug level in cancer patients

Study paves way for effective monitoring of chemotherapeutic drug level in cancer patients

Phase 3 DREAM3R trial opens for malignant pleural mesothelioma

Phase 3 DREAM3R trial opens for malignant pleural mesothelioma

Researchers create high throughput arrays of miniaturized 3D tumor models

Researchers create high throughput arrays of miniaturized 3D tumor models

New rodent model helps identify pregnant women whose prior kidney injury also affects babies

New rodent model helps identify pregnant women whose prior kidney injury also affects babies

Study characterizes cisplatin-induced hearing loss in pediatric cancer patients

Study characterizes cisplatin-induced hearing loss in pediatric cancer patients

Phase III study of (m)RNA expression did not confer significant advantage for stage II-III lung cancer

Phase III study of (m)RNA expression did not confer significant advantage for stage II-III lung cancer

Nivolumab monotherapy is effective treatment option for relapsed malignant mesothelioma

Nivolumab monotherapy is effective treatment option for relapsed malignant mesothelioma

Reduced-dose radiotherapy with cisplatin produces good outcomes for HPV-associated oropharyngeal cancer

Reduced-dose radiotherapy with cisplatin produces good outcomes for HPV-associated oropharyngeal cancer

Allarity Therapeutics announces plans to test antiviral activity of stenoparib drug

Allarity Therapeutics announces plans to test antiviral activity of stenoparib drug

Researchers discover a new approach to inhibit intrahepatic cholangiocarcinoma

Researchers discover a new approach to inhibit intrahepatic cholangiocarcinoma

Repurposed drug can treat hearing loss in humans

Repurposed drug can treat hearing loss in humans

Machine learning increases the accuracy of anti-cancer drug response predictions

Machine learning increases the accuracy of anti-cancer drug response predictions

Phase II NRG Oncology trial evaluates two regimens for muscle-invasive bladder cancer

Phase II NRG Oncology trial evaluates two regimens for muscle-invasive bladder cancer

Scientists combine a chemotherapeutic and photodynamic approach to fight cancer

Scientists combine a chemotherapeutic and photodynamic approach to fight cancer

Neoadjuvant trial of combination immunotherapy has favorable outcomes in bladder cancer patients

Neoadjuvant trial of combination immunotherapy has favorable outcomes in bladder cancer patients